Brief: ALX Oncology Reports Fourth Quarter And Full Year 2021 Financial Results

ALX Oncology Holdings

28/02/2022 12:29

Feb 28 (Reuters) - ALX Oncology Holdings Inc  ALXO.O :
    * ALX ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL
HIGHLIGHTS AND UPCOMING MILESTONES
    * Q4 GAAP LOSS PER SHARE $0.70
    * BELIEVES ITS CASH AND CASH EQUIVALENTS IS SUFFICIENT TO
FUND
PLANNED OPERATIONS THROUGH MID-2024
    * CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2021 WERE
$363.7
MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX2Zy84b 
Further company coverage:  ALXO.O 

 ((reuters.briefs@thomsonreuters.com;))